Project ticker / MED
MED
A verified medical-science hub for iPS translation, regenerative dentistry, AI drug-data work, and busy researchers who need a serious room.
Operating thesis
Japan has rare medical science depth. MED builds the connective tissue.
MED starts from a Kyoto-rooted science network: physics-trained founders, medical alumni, Dean's Club executives, iPS cell research lineage, Tokyo clinical excellence, pharmaceutical evidence pipelines, and a practical observation that dental regeneration sits between medicine, dentistry, materials science, and industry.
The first job is not to promise cures. The first job is to create a trusted room where MDs, PhDs, graduate students, corporate labs, university offices, AI agents, and selected operators can turn scattered expertise into consented problem packets, reviewable data work, and patent-ready disclosures.
MED is careful in v0.1: it does not claim formal Kyoto University, University of Tokyo, Science Tokyo, ministry, hospital, or company endorsement. Those names belong to their responsible owners until approved language exists.
Project rooms
Six rooms where busy professionals can enter without losing the thread.
Each room should produce a small public-safe packet, a private evidence trail, and a clear next reviewer.
iPS translation desk
Map where iPS science is close to usable translation and where AI can reduce literature, assay, manufacturing, safety, and evidence friction.
Tooth regeneration bridge
Treat regenerative dentistry as a serious cross-field problem: oral biology, stem cells, biomaterials, dental schools, hospitals, and patient-safe ethics.
AI drug-data room
Use AI to speed literature triage, compound and indication maps, trial evidence comparison, adverse-event signal review, and reviewer-ready summaries.
Verified professional graph
Arrange TempleMirror-style identity for researchers, MDs, PhDs, labs, alumni executives, and reviewers with consent, attribution, and privacy boundaries.
PAT disclosure route
Route early inventions into the PAT vertical: invention notes, prior-art maps, ownership questions, lawyer review, proof records, and filing decisions.
Corporate and university pilot desk
Give corporate research institutes and university labs a clean way to define pilots, success metrics, confidentiality, publication policy, and review cadence.
Operating workflow
Make it easy for the smartest people to contribute in minutes.
The workflow starts with respect for time, consent, and scientific review.
Invitation
One precise ask: review a topic, add a problem statement, nominate a collaborator, or flag a risk.
Verified identity
Optional TempleMirror-style verification separates public identity, private proof, and contribution credit.
Problem packet
Each idea becomes a one-page packet: clinical need, science basis, data needed, owner, and first reviewer.
AI triage
Agents summarize literature, datasets, patents, trials, and contradictions, then label uncertainty.
Human signoff
Medical and scientific reviewers approve what can be shared, what stays private, and what needs ethics review.
PAT route
Promising inventions move to PAT for disclosure discipline, proof records, patent counsel, and filing strategy.
First build queue
Start with problems that already have motivated reviewers.
Find the scientists, dental schools, materials labs, and clinical constraints that can make tooth regeneration a real discussion instead of a wish.
Track active iPS topics by indication, cell type, manufacturing question, safety bottleneck, and industry partner type.
Create one reviewer-approved workflow for literature tables, PMDA-style electronic evidence summaries, and patent/lit overlap checks.
Prepare a concise CEO-alumni ask that requests introductions, pilot framing, and corporate lab reviewers without overpromising.
Synthetic agent review
Six reviewer personas challenged the v0.1 site.
These are simulated first-pass reviewers, not real interviews. Their feedback is preserved for the next MED iteration.
Lead with scientific caution.
MED now says no cures, no patient recruitment, and no institutional endorsement before approval.
Dental regeneration needs its own bridge.
The site adds a dedicated tooth and oral-tissue room instead of hiding dentistry under medicine.
Clinical trust depends on governance.
Workflow now requires human signoff, ethics review routing, and separation of public/private evidence.
Define pilot entry points.
MED adds the corporate and university pilot desk with success metrics, confidentiality, and cadence.
Credit cannot disappear.
The professional graph and packets include consent, attribution, and publication-path checks.
Ticker language must stay disciplined.
The ticker section says MED is a project identity now, not an offer, security, or clinical claim.
Ticker and token discipline
MED can be a project ticker before it becomes anything financial.
MED should behave first like a research coordination identity: one name, one room, one clean artifact trail. If token mechanics are explored later, they should reward verified contribution, IP records, and governance work, not promise investment return or access to medical treatment.
Project ticker, research identity, agent-readable endpoints, review packets, PAT handoff, contribution proofs.
Clinical advice, treatment claims, patient recruitment, token sale, investment-return language, unapproved university branding.